Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,749
datasets available to search
ShareScore release 0.7.1
Dataset results
11,749 results for “Patient safety”
Antimicrobial Stewardship & Patient Safety Improvements: Introducing the NIVAS Line Flushing Guidance
<p>Recent published literature highlights that as much as 35% [1] of medication may remain in the infusion line as residual volume. The line is not commonly flushed outside of paediatric and oncology settings and therefore the total prescribed dose is not administered to patients, and this residual medication is discarded, raising the issue of underdosing. [2]</p><p> </p><p>At Salisbury NHS Foundation Trust, the Medical Device Management Services team is actively working towards improving patient safety and recovery through antimicrobial stewardship and compliance with new NIVAS guidelines [3]. We were keen to understand the implications of current intravenous administration practice at our Trust. We were particularly interested in assessing the prevalence and extent to which patients are underdosed, and the cost implications of discarded medication.</p>
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
ClinicalTrials.gov study NCT01374906. IPD Sharing: UNDECIDED. Countries: 20. Publications: 5.
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
ClinicalTrials.gov study NCT02228096. IPD Sharing: YES. Countries: 1. Publications: 4.
Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
ClinicalTrials.gov study NCT02586805. IPD Sharing: YES. Countries: 7. Publications: 4.
Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo
ClinicalTrials.gov study NCT02798211. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PA
ClinicalTrials.gov study NCT03988634. IPD Sharing: YES. Countries: 2. Publications: 6.
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
ClinicalTrials.gov study NCT02962895. IPD Sharing: YES. Countries: 19. Publications: 1.
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT03578367. IPD Sharing: YES. Countries: 15. Publications: 1.
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Anti
ClinicalTrials.gov study NCT03738215. IPD Sharing: YES. Countries: 7. Publications: 1.
Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
ClinicalTrials.gov study NCT03328897. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges
ClinicalTrials.gov study NCT02336451. IPD Sharing: YES. Countries: 17. Publications: 1.
A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment
ClinicalTrials.gov study NCT01610336. IPD Sharing: YES. Countries: 14. Publications: 1.
Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03005288. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
ClinicalTrials.gov study NCT03474965. IPD Sharing: YES. Countries: 14. Publications: 1.
Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
ClinicalTrials.gov study NCT03612856. IPD Sharing: YES. Countries: 1. Publications: 2.
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
ClinicalTrials.gov study NCT03610724. IPD Sharing: YES. Countries: 14. Publications: 1.
Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
ClinicalTrials.gov study NCT03963895. IPD Sharing: YES. Countries: 1. Publications: 2.
Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
ClinicalTrials.gov study NCT02038036. IPD Sharing: YES. Countries: 12. Publications: 3.
Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
ClinicalTrials.gov study NCT03569475. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT01892722. IPD Sharing: UNDECIDED. Countries: 25. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.